William T. Burnett

Emergency Medicine
701 Grove Rd
Greenville, SC 29605

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Ofirnoflast: a first-in-class NEK7-targeted inhibitor of the NLRP3 inflammasome.

Ofirnoflast: a first-in-class NEK7-targeted inhibitor of the NLRP3 inflammasome.

Journal: Journal of drug targeting
Published: August 04, 2025
Showing 1-1 of 1

Last Updated: 09/26/2026